Juan Tao
Papers
1
Total Citations
13
H-Index
1
About
Juan Tao is a pathologist whose research focuses on the morphological and molecular characterization of rare renal cell carcinomas (RCC), particularly those with overlapping features that challenge existing classification systems. His major contribution lies in elucidating the genetic underpinnings of diagnostically challenging kidney tumors, as demonstrated in his highly cited 2022 case report describing a unique RCC exhibiting both haemangioblastoma-like features and leiomyomatous stroma. This work identified concurrent *TSC2* and *SETD2* variations, providing critical insights into the molecular drivers of these rare entities and their potential relationship to the TSC/mTOR pathway. With 13 citations, this study has become a key reference for pathologists and researchers navigating the evolving landscape of renal tumor classification, including provisional entities like RCC with leiomyomatous stroma (RCCLMS) from the 2016 WHO classification. By bridging histomorphology and genomics, Tao’s work aids in refining diagnostic criteria and uncovering therapeutic targets for these uncommon neoplasms, making him a valuable contributor to the field of urologic pathology.
Research Focus
Key Achievements
Top Papers
- 1